4//SEC Filing
Townsend Christopher G 4
Accession 0001209191-17-059597
CIK 0001099219other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 4:16 PM ET
Size
14.5 KB
Accession
0001209191-17-059597
Insider Transaction Report
Form 4
METLIFE INCMET
Townsend Christopher G
President, Asia Region
Transactions
- Exercise/Conversion
Common Stock
2017-11-03$27.19/sh+49,660$1,350,255→ 49,660 total - Sale
Common Stock
2017-11-03$54.60/sh−49,660$2,711,684→ 0 total - Exercise/Conversion
Common Stock
2017-11-03$31.15/sh+33,071$1,030,162→ 33,071 total - Sale
Common Stock
2017-11-03$54.60/sh−33,071$1,805,743→ 0 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-11-03−49,660→ 0 totalExercise: $27.19Exp: 2022-07-31→ Common Stock (49,660 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-11-03−33,071→ 0 totalExercise: $31.15Exp: 2023-02-25→ Common Stock (33,071 underlying)
Footnotes (5)
- [F1]The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F2]The shares were sold in multiple transactions at prices $54.560 to $54.630, inclusive.
- [F3]The shares were sold in multiple transactions at prices $54.600 to $54.618, inclusive.
- [F4]The options became exercisable in three equal installments on August 1, 2013, 2014 and 2015.
- [F5]The options became exercisable in three equal installments on February 26, 2014, 2015 and 2016.
Documents
Issuer
METLIFE INC
CIK 0001099219
Entity typeother
Related Parties
1- filerCIK 0001555359
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 4:16 PM ET
- Size
- 14.5 KB